Comment Letters

  • RE: Ultrasound for Diagnostic Evaluation of Goiter Suspected or Detected on Physical Examination Dear Director Teeter: The Medical Imaging and Technology Alliance (MITA) is pleased to submit comments on the Washington State Health Care Authority Draft Key Questions on Ultrasound for Diagnostic Evaluation of Goiter Suspected or Detected on Physical Examination (“Draft Key Questions”). As Read More

  •   RE:  National Coverage Analysis (NCA) Tracking Sheet for Lung Cancer Screening with Low Dose Computed Tomography (CAG-00439N) Dear Ms. Jensen: The Medical Imaging and Technology Alliance (MITA) is pleased to submit comments on the Centers for Medicare and Medicaid Services’ (CMS) national coverage analysis (NCA) tracking sheet on lung cancer screening with low dose Read More

  • Dear Dr. Berliner: The Medical Imaging & Technology Alliance (MITA) is pleased to submit comments on the Agency for Healthcare Research and Quality (AHRQ) draft technical brief entitled Imaging Techniques for Treatment Evaluation for Metastatic Breast Cancer (“Draft Technical Brief”). MITA has extensive knowledge of the substantial benefits afforded by medical imaging and radiation therapy Read More

  • RE: AHRQ Draft Key Questions on Non-Invasive Testing for Coronary Artery Disease Dear Dr. Kronick: The Medical Imaging & Technology Alliance (MITA) is pleased to submit comments on the Agency for Healthcare Research and Quality (AHRQ) draft key questions entitled Non-Invasive Testing for Coronary Artery Disease (“Draft Key Questions”). MITA has extensive knowledge of the Read More

  • Dear Chairwoman Moyer: The Medical Imaging and Technology Alliance (MITA) is pleased to submit comments on the United States Preventive Services Task Force (USPSTF) Draft Research Plan on Screening for Colorectal Cancer (“Draft Research Plan”). As the leading trade association representing medical imaging, radiotherapy, and radiopharmaceutical manufacturers, we have in-depth knowledge of the significant benefits Read More

  • Dear Administrator Tavenner: The Medical Imaging and Technology Alliance (MITA) is pleased to submit comments on the Centers for Medicare and Medicaid Services’ (CMS) final rule regarding the payment policies under the physician fee schedule (PFS) for calendar year 2014 (CY 2014), published in the Federal Register on December 10, 2013 (the “Final Rule”). As Read More

  • Dear Dr. Isham and Dr. McGlynn: The Medical Imaging and Technology Alliance (MITA) is pleased to submit comments on the Measures Application Partnership (MAP) 2014 Draft Pre-Rulemaking Report (“draft report”) published for public comment in January 2014 which includes 234 measures for consideration to comply with Section 1890A of the Social Security Act. As the Read More

  • RE: AHRQ Draft Comparative Effectiveness Review of Imaging Techniques for the Surveillance, Diagnosis, and Staging of Hepatocellular Carcinoma   Dear Dr. El-Kassar: The Medical Imaging & Technology Alliance (MITA) is pleased to submit comments on the Agency for Healthcare Research and Quality (AHRQ) draft comparative effectiveness review entitled Imaging Techniques for the Surveillance, Diagnosis, and Read More

  • RE: AHRQ Draft Comparative Effectiveness Review on Imaging Tests for the Diagnosis and Staging of Pancreatic Adenocarcinoma  Dear Dr. El-Kassar:  The Medical Imaging & Technology Alliance (MITA) is pleased to submit comments on the Agency for Healthcare Research and Quality (AHRQ) draft comparative effectiveness review entitled Imaging Tests for the Diagnosis and Staging of Pancreatic Read More

  • Dear Chairwoman Moyer: The Medical Imaging & Technology Alliance (MITA) is pleased to submit comments on the United States Preventive Services Task Force (USPSTF)Draft Research Plan on Screening for Breast Cancer (“Draft Research Plan”). MITA has extensive knowledge of the substantial benefits afforded by medical imaging and radiation therapy to the health of Americans due Read More